Efficacy and Safety Study of TPN171H Tablets in Erectile Dysfunction.

PHASE3CompletedINTERVENTIONAL
Enrollment

765

Participants

Timeline

Start Date

December 31, 2021

Primary Completion Date

February 14, 2023

Study Completion Date

February 14, 2023

Conditions
Erectile Dysfunction
Interventions
DRUG

TPN171H 2.5mg group

TPN171H 2.5mg taken orally on demand 0.5-4 hour prior to sexual intercourse

DRUG

TPN171H 5mg group

TPN171H 5mg taken orally on demand 0.5-4 hour prior to sexual intercourse

DRUG

TPN171H 10mg group

TPN171H 10mg taken orally on demand 0.5-4 hour prior to sexual intercourse

DRUG

Placebo group

Placebo taken orally on demand 0.5-4 hour prior to sexual intercourse

Trial Locations (49)

35004

The First Affiliated Hospital of Fujian Medical University, Fuzhou

100000

Peking Union Medical College Hospital, Beijing

Peking University Shougang Hospital, Beijing

Xiyuan Hospital china Academy of chinese Medical Sciences, Beijing

100191

Peking University Third Hospital, Beijing

116011

The First Affiliated Hospital of Dalian Medical University, Dalian

130021

The Affiliated Hospital to Changchun University of Traditional Medicine, Changchun

130061

The Frist Hospital of Jilin University, Changchun

200065

Tongji Hospital of Tongji University, Shanghai

200940

Shanghai Ceneral Hospital, Shanghai

201399

Shanghai Pudong Hospital ,Fudan university PuDong Medical center, Shanghai

210004

Jiangsu Provincial Hospital of Chinese Medicine, Nanjing

210008

Nanjing Drum Tower Hospital, Nanjing

215004

The Second Affiliated Hospital of Soochow University, Suzhou

215104

Tongji Medical College of HUST, Wuhan

221004

The Affiliated Hospital of Xuzhou Medical University, Xuzhou

230012

The Second People's Hospital of Hefei, Hefei

230022

The First Affiliated Hospital of Anhui Medical University, Hefei

230601

The Second Hospital of Anhui Medical University, Hefei

241004

The first affiliated Hospital of Wannan Medical College, Wuhu

250021

Shandong Provincial Hospital, Jinan

310014

Zhejiang Provincial People's Hospital, Hangzhou

325015

The First Affiliated Hospital of Wenzhou Medical University, Wenzhou

330001

Nanchang reproductive hospital, Nanchang

330006

First Affiliated Hospital of Nanchang University, Nanchang

361003

The First Affiliated Hospital of Xiamen University, Xiamen

410013

The Third Xiangya Hospital of Central South University, Changsha

430014

The Central Hospital of Wuhan, Wuhan

450003

Henan Provincial People's Hospital, Zhenzhou

450053

People's Hospital of zhengzhou, Zhengzhou

510180

Guangzhou First People's Hospital, Guangzhou

510515

Southern Medical University Nanfang Hospital, Guangzhou

510700

The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou

518071

Shenzhen University General Hospital, Shenzhen

518105

Songgang People's Hospital, Shenzhen

519099

Zhuhai People's Hospital, Zhuhai

528406

The Eighth Affiliated Hospital Sun Yat-sen University, Shenzhen

530031

The Second Nanning People's Hospital, Nanning

545026

Liuzhou peopleˊs Hospital, Liuzhou

570102

The First Affiliated Hospital of Hainan Medical University, Haikou

610072

Sichuan Academy of Medical Sciences.Sichuan Provincial People's Hospital, Chengdou

610081

Clinical Medical College & Affiliated Hospital of Chengdu University, Chengdou

730030

Lanzhou University Second Hospital, Lanzhou

750003

General Hospital of Ningxia Medical University, Yinchuan

810012

Qinghai university affiliated hospital, Xining

050000

The Second Hospital of Hebei Medical University, Shijiazhuang

Unknown

The First Affiliated Hospital of Soochow University, Suzhou

The Second Affiliated Hospital of Dalian Medical University, Dalian

030001

First Hospital of Shanxi Medical University, Taiyuan

All Listed Sponsors
lead

Vigonvita Life Sciences

INDUSTRY

NCT05188989 - Efficacy and Safety Study of TPN171H Tablets in Erectile Dysfunction. | Biotech Hunter | Biotech Hunter